Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- CheckyesterdayChange DetectedThe page's revision tag has been updated from v3.5.4 to v3.5.5, indicating a minor update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedOn 2026-05-18, the history adds the Contacts/Locations and Study Status sections to the record, expanding the visible information about who to contact and the trial's current status. A prior entry dated 2026-03-16 is removed from the history.SummaryDifference0.2%

- Check22 days agoChange DetectedA new revision entry labeled v3.5.4 is added to the history, replacing the previous v3.5.3 entry. This reflects an update to the record's versioning in the study history.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision line now shows v3.5.3, replacing the previous v3.5.2, signaling a new frontend deployment for this page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe record history shows Revision: v3.5.2 replacing Revision: v3.5.0.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.5.0 has been added to the history and Revision: v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.